STAT+: European regulators approve $16.5 billion deal for Novo Holdings to buy Catalent

The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of Novo Nordisk, one of the largest pharmaceutical companies, would pay $16.5 billion…